CORRECTING and REPLACING Massachusetts Specialty Pharmacy Announces Voluntary Recall

WALTHAM, Mass.--(BUSINESS WIRE)--

First graph, second sentence of release should read: The recall resulted after particulate was discovered in a small percentage of two lots of Progesterone (sted The recall resulted after particulate was discovered in a small percentage of one lot of Progesterone).

The corrected release reads:

MASSACHUSETTS SPECIALTY PHARMACY ANNOUNCES VOLUNTARY RECALL

Village Fertility Pharmacy is conducting a voluntary recall of compounded medications shipped over the past three months. The recall resulted after particulate was discovered in a small percentage of two lots of Progesterone. Immediately upon learning of the situation, Village contacted the Massachusetts Board of Pharmacy.

After an initial investigation, Village and the Massachusetts Board of Pharmacy decided to expand the recall to include one other medication, Leuprolide. More testing is being conducted and results will be released in the coming days.

We are working cooperatively with all government agencies and are awaiting the results of the investigation, according to Stuart Levine, president of Village Fertility Pharmacy. While no patients have reported any adverse effects, we believe the prudent course is to recall all of these medications.

The recall includes:

Progesterone is a hormone that supports gestation. It is compounded in different solutions to accommodate patients various needs. Leuprolide suppresses natural ovulation.

Village Fertility Pharmacy is a pharmacist-owned and operated specialty fertility pharmacy dedicated to providing exceptional service and educational resources to fertility patients and clinics. Compounding represents five percent of the companys total work.

Read the original here:
CORRECTING and REPLACING Massachusetts Specialty Pharmacy Announces Voluntary Recall